Active Ingredient: TIGECYCLINE
Proprietary Name: TIGECYCLINE
Dosage Form; Route of Administration: POWDER; INTRAVENOUS
Strength: 50MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N208744
Product Number: 001
Approval Date: Jan 18, 2018
Applicant Holder Full Name: ACCORD HEALTHCARE INC USA
Marketing Status:
Prescription
Patent and Exclusivity Information
